ACTIVE

J&L PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

38,4 k €

-9.4% YoY

Gross margin

54,5 k €

-21.7% YoY

Equity

385,9 k €

+7.6% YoY

What does J&L PHARMA do?

J&L PHARMA is a Private limited company incorporated in 2012. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Antwerpen.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0849.895.390

Incorporation

25/10/2012

Legal form

Private limited company

Registered office

Justitiestraat 81
2018 Antwerpen · FlandreSee on map

Contributed capital

12 500,00 €

Latest accounts

31/12/2025

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 64200Activities of holding companies 64210Activities of holding companies 70200Management consultancy activities 70220Business and other management consultancy activities

Signals

ProfitableSolid equityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 13 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013
Income statement
Gross margin	54,5 k €	-21.7%	69,6 k €	+64.9%	42,2 k €	-21.3%	53,7 k €	-13.5%	62,1 k €	+25.7%	49,4 k €	-1.6%	50,2 k €	-10.8%	56,3 k €	+8.8%	51,7 k €	+27.2%	40,6 k €	-36.2%	63,7 k €	-26.3%	86,5 k €	+36.7%	63,3 k €
EBITDA	54,2 k €	-22.0%	69,5 k €	+66.0%	41,9 k €	-21.9%	53,6 k €	-13.1%	61,6 k €	+25.0%	49,3 k €	-1.6%	50,1 k €	-8.5%	54,7 k €	+25.6%	43,6 k €	+22.6%	35,6 k €	-43.1%	62,5 k €	-26.8%	85,3 k €	+40.7%	60,6 k €
Operating result	53,6 k €	-21.9%	68,6 k €	+67.4%	41 k €	-23.2%	53,3 k €	-13.5%	61,6 k €	+25.0%	49,3 k €	-1.6%	50,1 k €	-8.5%	54,7 k €	+25.6%	43,6 k €	+22.6%	35,6 k €	-43.1%	62,5 k €	-26.8%	85,3 k €	+43.2%	59,6 k €
Net result	38,4 k €	-9.4%	42,4 k €	+72.3%	24,6 k €	-21.6%	31,4 k €	-9.1%	34,5 k €	+20.0%	28,8 k €	+0.7%	28,6 k €	-11.5%	32,3 k €	+166%	12,1 k €	-28.0%	16,8 k €	-65.2%	48,3 k €	-11.1%	54,4 k €	+69.9%	32 k €
Balance sheet
Equity	385,9 k €	+7.6%	358,5 k €	+13.4%	316,2 k €	+8.4%	291,6 k €	+12.1%	260,2 k €	+15.3%	225,7 k €	+14.6%	196,9 k €	+17.0%	168,4 k €	+21.0%	139,1 k €	+9.5%	127 k €	+15.3%	110,2 k €	+48.2%	74,4 k €	+85.9%	40 k €
Total assets	664,5 k €	-2.2%	679,7 k €	+1.8%	667,5 k €	+0.2%	666,4 k €	+0.6%	662,4 k €	-0.8%	667,5 k €	+1.3%	658,8 k €	+0.2%	657,5 k €	-4.1%	685,5 k €	-2.5%	702,9 k €	+2.9%	683,1 k €	+0.3%	680,8 k €	-0.7%	685,3 k €
Cash	3,7 k €	-2.8%	3,8 k €	+4494%	82,6 €	+115%	38,4 €	-98.8%	3,3 k €	+666%	426,9 €	-64.6%	1,2 k €	-6.8%	1,3 k €	-79.1%	6,2 k €	-8.1%	6,7 k €	+223%	2,1 k €	0.0%	2,1 k €	-68.2%	6,6 k €
Debts	272,6 k €	-15.1%	321,2 k €	-8.6%	351,4 k €	-6.1%	374,3 k €	-6.9%	402,2 k €	-8.2%	438 k €	-5.2%	461,9 k €	-5.6%	489,1 k €	-10.5%	546,3 k €	-5.1%	575,7 k €	+0.5%	572,7 k €	-5.1%	603,7 k €	-5.9%	641,7 k €
Other
Workforce	–		–		–		–		–		–		–		–		–		1,0 ETP		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 2 ended

Active mandates

Sarina Van Belle

Director

Active

Ended mandates

SARINA VAN BELLE

Manager · since 25 octobre 2012

Ended

SARINA VAN BELLE

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
APOTHEEK JUSTITIA● Active	0463.774.519
J & L DENTAL● Active	0715.955.713

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	23/06/2026	24/07/2025	12/07/2024	02/08/2023	31/12/2022	31/08/2021
General meeting	22/06/2026	23/06/2025	24/06/2024	26/06/2023	27/06/2022	28/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

13 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	22/06/2026	23/06/2026	Dutch	PDF
Abridged model	31/12/2024	23/06/2025	24/07/2025	Dutch	PDF
Micro model	31/12/2023	24/06/2024	12/07/2024	Dutch	PDF
Micro model	31/12/2022	26/06/2023	02/08/2023	Dutch	PDF
Micro model	31/12/2021	27/06/2022	31/12/2022	Dutch	PDF
Micro model	31/12/2020	28/06/2021	31/08/2021	Dutch	PDF
Micro model	31/12/2019	22/06/2020	31/10/2020	Dutch	PDF
Micro model	31/12/2018	24/06/2019	31/08/2019	Dutch	PDF
Micro model	31/12/2017	25/06/2018	30/09/2018	Dutch	PDF
Abridged model	31/12/2016	26/06/2017	11/01/2018	Dutch	PDF
Abridged model	31/12/2015	27/06/2016	09/01/2017	Dutch	PDF
Abridged model	31/12/2014	22/06/2015	30/12/2015	Dutch	PDF
Abridged model	31/12/2013	23/06/2014	26/03/2015	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 2 ended

Active mandates

Sarina Van Belle

Director

Active

Ended mandates

SARINA VAN BELLE

Manager · since 25 octobre 2012

Ended

SARINA VAN BELLE

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates17/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/01/2013
ONTSLAGEN - BENOEMINGEN
PDF
Other29/10/2012
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202538,4 k €↓
2024
Annual accounts 202442,4 k €↑
2023
Annual accounts 202324,6 k €↓
2022
Annual accounts 202231,4 k €↓
2021
Annual accounts 202134,5 k €↑
2020
Annual accounts 202028,8 k €↑
2019
Annual accounts 201928,6 k €↓
2018
Annual accounts 201832,3 k €↑
2017
Annual accounts 201712,1 k €↓
2016
Annual accounts 201616,8 k €↓
2015
Annual accounts 201548,3 k €↓
2014
Annual accounts 201454,4 k €↑
2013
Annual accounts 201332 k €
25/10/2012
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

J&L PHARMA

Overview

What does J&L PHARMA do?

Trend over 13 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline